3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Neoplasms
38
Breast Neoplasms
31
Lung Neoplasms
25
Colorectal Neoplasms
15
Prostatic Neoplasms
13
Pancreatic Neoplasms
11
Ovarian Neoplasms
11
Carcinoma, Non-Small-Cell Lung
10
Head and Neck Neoplasms
9
Sarcoma
8
Colonic Neoplasms
8
Carcinoma, Hepatocellular
8
Uterine Cervical Neoplasms
7
Glioma
7
Esophageal Neoplasms
7
Melanoma
6
Lymphoma
6
Endometrial Neoplasms
6
Neoplastic Cells, Circulating
5
Multiple Myeloma
5
Brain Neoplasms
5
Stomach Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Neoplasm, Residual
4
Gastrointestinal Neoplasms
4
Carcinoma, Squamous Cell
4
Carcinoma, Renal Cell
4
Adenocarcinoma
4
Thrombosis
3
Rectal Neoplasms
3
Interventions
venetoclax
4
fludarabine
3
gilteritinib
2
aldesleukin
2
Whole-Body Irradiation
2
Interleukin-2
2
Cytarabine
2
Cyclophosphamide
2
nicotinamide-beta-riboside
1
fludarabine phosphate
1
blinatumomab
1
asciminib
1
Thiotepa
1
Tacrolimus
1
Sirolimus
1
Peripheral Blood Stem Cell Transplantation
1
N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide
1
Mycophenolic Acid
1
Mitoxantrone
1
Methotrexate
1
Idarubicin
1
Hyperbaric Oxygenation
1
Granulocyte Colony-Stimulating Factor
1
Busulfan
1
Bone Marrow Transplantation
1
Blood Specimen Collection
1
Azacitidine
1
Allopurinol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Leukemia, Myeloid
×
Blood Specimen Collection
×
Clear all
NCT06537726
2025-04-10
REDEFINE
University of Zurich
Recruiting
130 enrolled